If a biotech noob read the Decitabine news I doubt they can understand the implications. We would need another Triangle report for that to quantify the market potential for Dec in solid tumours thanks to Bis.
Btw, apart from owing Race one would also could consider buying Otsuka shares due to the Dec Ann
No advice.
Ann: RAC Investor Presentation May 2024, page-44
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
-0.080(4.73%) |
Mkt cap ! $277.7M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.66 | $1.57 | $275.0K | 168.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 625 | $1.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.62 | 650 | 1 |
View Market Depth
| Last trade - 14.51pm 04/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |